
PhaseV is a Boston-based technology company that leverages advanced causal machine learning and GenAI, augmented by an expansive data lake and real-world data (RWD), to empower biopharma sponsors and…

PhaseV is a Boston-based technology company that leverages advanced causal machine learning and GenAI, augmented by an expansive data lake and real-world data (RWD), to empower biopharma sponsors and…
Founded: 2023
Headquarters: Cambridge / Boston, MA
Sector: AI/ML for clinical trial optimization (biopharma/CRO)
Customers: 30–45+ biopharma and CRO customers (company claims)
Funding: Series A on 2025-05-13; total funding reported ~$65M
Clinical trial design and operations optimization, subgroup/heterogeneous treatment effect analysis, adaptive and Bayesian trial implementation.
2023
Pharmaceutical Manufacturing
Seed round participation included Viola Ventures
Series A reported as led by Accel and Insight Partners
“Participation from Accel, Insight Partners, Exor Ventures, Viola Ventures, LionBird”
| Company |
|---|
Company Description
PhaseV, headquartered in Boston, is a pioneering technology company revolutionizing clinical development through its AI/ML-powered platform. By leveraging innovative tools like the Trial Optimizer, ClinOps Optimizer, and Lifecycle Management module, PhaseV helps sponsors and CROs optimize every stage of clinical trials. The company's solutions enhance study design, improve site selection, and support informed portfolio decisions. With a proven track record of reducing costs, shortening timelines, and increasing the probability of success, PhaseV empowers organizations to achieve efficient and effective clinical development outcomes.
Role Description
We're seeking a talented, experienced Product Manager to join our Tel Aviv team. In this role, you'll tackle the thrilling challenge of building an intuitive, efficient platform that redefines how clinical trials are designed and conducted, leveraging AI and innovation to transform drug development. You'll collaborate closely with our engineering, data science, algorithm research, and clinical teams to create and refine a state‑of‑the‑art trials platform. This is a rare opportunity to make a tangible impact on how new therapies reach patients and to revolutionize healthcare delivery.
Key Responsibilities
Required Qualifications
About Us
PhaseV (HQ in Boston, R&D in Tel Aviv) is a fast-moving startup redefining clinical trial design with a cloud-native, AI-first platform. Founded in 2023, we combine causal machine learning, adaptive trial design, and real-world data to deliver smarter, faster, and more efficient drug development.
Backed by a $50 million Series A, we’re enabling sponsors, biotechs, and CROs to uncover hidden insights, optimize trial scenarios in real time, and accelerate the path from molecule to medicine.
At PhaseV, every innovation has one destination: speeding critical treatments from lab to patient.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,400+
New This Week